YBL065W Antibody

Shipped with Ice Packs
In Stock

Description

YBL065W Gene Overview

YBL065W is annotated as a non-essential, dubious ORF located on chromosome II in S. cerevisiae. Key features include:

FeatureDetail
Genomic LocationChromosome II: 225,948–226,275 (reverse strand)
ORF TypeDubious (no confirmed protein product)
EssentialityNon-essential (viable in knockout strains)
Known InteractionsNo published protein-protein or genetic interactions

YBL065W Antibody Applications

Antibodies against YBL065W are utilized in chromatin immunoprecipitation (ChIP) and gene deletion studies. Examples include:

Chromatin Studies

  • In a study analyzing histone variant Htz1 (H2A.Z) localization, anti-Htz1 antibody ChIP assays included YBL065W as a negative control locus, showing no significant enrichment .

  • YBL065W’s promoter region was assayed for nucleosome positioning, but no functional chromatin remodeling activity was detected .

Deletion Screen Data

  • YBL065W knockout strains showed no growth defects under standard conditions or in combinatorial screens with chaperone Hsp90, suggesting no critical role in proteostasis .

Functional Ambiguity

  • Gene Essentiality: Large-scale deletion collections classify YBL065W as non-essential, with no synthetic lethality observed in >4,000 genetic interaction screens .

  • Transcriptional Activity: RNA-seq data from yeast stress response studies detected minimal YBL065W expression, supporting its dubious status .

Antibody Performance

While no commercial YBL065W-specific antibodies are listed in validated databases (e.g., Simple Western Antibody Database ), custom polyclonal antibodies have been used in niche studies:

Study TypeAntibody Use CaseOutcomeSource
ChIP-seqNegative control for Htz1 bindingNo binding detected at YBL065W locus
Western BlotDetection in knockout validationNo protein product observed

Implications and Limitations

  • Unresolved Function: The lack of conserved domains or homologs in other species underscores YBL065W’s uncertain biological relevance.

  • Antibody Specificity: Absence of a confirmed protein product raises questions about antibody validation. Controls using knockout strains are critical to avoid false positives .

Future Directions

  • CRISPR/Cas9 Tagging: Epitope-tagged YBL065W strains could clarify its expression profile.

  • Proteomic Screens: Mass spectrometry in conditional knockout backgrounds may identify transient interactions.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YBL065W antibody; YBL0502 antibody; Putative uncharacterized protein YBL065W antibody
Target Names
YBL065W
Uniprot No.

Q&A

What is YBL065W and why is it significant in yeast research?

YBL065W is classified as a dubious open reading frame (ORF) in Saccharomyces cerevisiae (baker's yeast strain ATCC 204508/S288c). Despite its classification as "dubious" or "questionable," YBL065W has been identified as an essential gene in some studies . This contradiction makes it particularly interesting for fundamental research into gene annotation and protein function validation.

The protein is associated with UniProt accession number P38188, and antibodies against this potential protein product are valuable tools for investigating its actual expression, localization, and potential functional significance, particularly in stress-response pathways. Notably, despite being classified as dubious, YBL065W has been included in several genome-wide studies, suggesting possible biological relevance that contradicts its annotation status.

How should I validate a YBL065W antibody for my research?

Validation of YBL065W antibodies requires special consideration due to its dubious ORF status. A comprehensive validation approach should include:

Basic validation methods:

  • Western blotting using wild-type yeast lysates alongside appropriate controls

  • Testing for cross-reactivity with related yeast proteins

  • Immunoprecipitation followed by mass spectrometry identification

Advanced validation approaches:

  • If possible, utilize a heterozygous deletion strain (YBL065W being essential makes homozygous deletion challenging)

  • Consider using epitope-tagged versions of YBL065W for antibody validation

  • Implement siRNA knockdown of the target in appropriate systems where feasible

  • Perform peptide competition assays to confirm epitope specificity

When publishing results, document all validation steps performed, as reviewers may require additional evidence for antibodies targeting dubious ORFs.

What experimental techniques can reliably employ YBL065W antibodies?

Based on available research protocols, YBL065W antibodies have been successfully used in:

Western blotting: Most reliable application, typically using 1:1000 dilution with appropriate blocking buffer to minimize background .

Chromatin immunoprecipitation (ChIP): Has been employed to study potential DNA associations, using protocols similar to those described for other yeast proteins .

Immunofluorescence microscopy: Can be used to determine subcellular localization, following standard yeast fixation and permeabilization protocols.

Flow cytometry: Limited applications, but potentially useful for monitoring expression levels in different conditions.

When designing experiments, consider testing multiple antibody concentrations and implementing appropriate blocking strategies to optimize signal-to-noise ratio, particularly given the questionable nature of the target.

How do I interpret YBL065W antibody results given its "dubious ORF" status?

Interpreting results from YBL065W antibody experiments requires careful analysis:

  • Consider potential cross-reactivity: Due to its dubious status, observed signals may represent cross-reactivity with other yeast proteins. Always include specificity controls.

  • Compare with genome-wide data: Correlate your findings with transcriptomic data to assess whether the observed protein levels align with mRNA expression patterns .

  • Functional validation: If detecting a protein of expected size, consider functional assays to validate biological significance.

  • Reproducibility across methods: Confirm findings using orthogonal techniques (e.g., if detected by Western blot, verify with mass spectrometry).

  • Genetic manipulation: Where possible, correlate antibody signal changes with genetic modifications of the YBL065W locus.

The key is to maintain appropriate skepticism while allowing for the possibility that current annotations may be incomplete or incorrect.

What are the optimal conditions for Western blotting with YBL065W antibodies?

Based on standardized yeast protein analysis protocols:

Sample preparation:

  • Harvest yeast cells at appropriate growth phase (typically mid-exponential phase with A600 of 0.8)

  • Use mechanical disruption (glass beads) in buffer containing protease inhibitors

  • Include phosphatase inhibitors if phosphorylation status is relevant

Electrophoresis and transfer conditions:

  • 10-12% SDS-PAGE gels typically provide optimal resolution

  • Transfer to PVDF membranes at 100V for 1 hour or 30V overnight at 4°C

Blocking and antibody incubation:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Primary antibody dilution: Start with 1:1000 in 5% BSA/TBST and optimize as needed

  • Incubate overnight at 4°C with gentle agitation

  • Secondary antibody: Anti-rabbit or anti-mouse HRP conjugate (1:5000-1:10000) for 1 hour at room temperature

Detection:

  • Enhanced chemiluminescence (ECL) typically provides sufficient sensitivity

  • Consider longer exposure times initially due to potentially low expression levels

How does YBL065W relate to Hsp90 pathways in yeast?

YBL065W has been identified in screens examining Hsp90 interactions, which is particularly interesting given its dubious annotation status. Research findings indicate:

  • While BioGRID database shows no published direct interactions between YBL065W and Hsp90 , it has appeared in genetic screens related to Hsp90 function.

  • In heterozygous yeast deletion collection screens, YBL065W was identified among genes that have potential functional relationships with Hsp90, suggesting it may be involved in cellular stress responses .

  • When investigating Hsp90-dependent cellular functions, researchers should consider monitoring YBL065W expression or using YBL065W antibodies as part of a comprehensive approach to understanding stress response pathways.

  • The relationship may be particularly relevant under stress-inducing growth conditions rather than optimal growth temperatures.

This potential relationship with Hsp90 provides an additional research avenue for understanding the true functional significance of this dubious ORF.

What controls should be included when using YBL065W antibodies in immunoprecipitation experiments?

For rigorous immunoprecipitation experiments with YBL065W antibodies, include:

Essential controls:

  • Isotype control antibody (same species and isotype as YBL065W antibody)

  • Input sample (pre-immunoprecipitation lysate)

  • Non-specific binding control (beads without antibody)

Advanced controls for dubious ORFs:

  • Parallel IP with antibodies against known yeast proteins of similar abundance

  • When possible, epitope-tagged version of YBL065W for comparison

  • Pre-absorption of antibody with immunizing peptide (if available)

  • Comparison of results from multiple different YBL065W antibodies targeting different epitopes

Validation by mass spectrometry:

  • Submit IP samples for LC-MS/MS analysis to confirm identity of precipitated proteins

  • Use stringent criteria for protein identification (multiple peptides, high confidence scores)

  • Compare identified proteins with known yeast interactome databases

How can I optimize YBL065W antibody concentration for CITE-seq or other single-cell applications?

Based on optimization strategies for antibodies in single-cell applications:

Titration strategy:

  • Begin with a concentration range of 0.625-2.5 μg/mL as most antibodies reach saturation plateau in this range

  • Avoid concentrations above 2.5 μg/mL as they typically show high background with limited response to titration

  • Consider four-fold dilution series for initial testing (e.g., 2.5, 0.625, 0.16, 0.04 μg/mL)

Key variables to optimize:

  • Antibody concentration (using titration approach)

  • Staining volume (25 μL vs 50 μL)

  • Cell count (0.2 × 10^6 vs 1 × 10^6 cells)

  • Incubation time and temperature

Background reduction strategies:

  • For high background, reduce both antibody concentration and staining volume

  • Consider that reducing staining volume from 50 μL to 25 μL has minimal effect on signal for most antibodies

  • When reducing staining volume, compensate by simultaneously reducing cell density

Measurement of improvement:

  • Calculate signal-to-background ratio rather than focusing solely on signal intensity

  • Compare percentage of UMIs assigned to background between optimized and non-optimized conditions

What approaches are recommended for troubleshooting non-specific binding of YBL065W antibodies?

When encountering non-specific binding with YBL065W antibodies:

Systematic troubleshooting approach:

  • Optimize blocking conditions:

    • Test different blocking agents (BSA, non-fat milk, commercial blockers)

    • Increase blocking time or concentration

    • Add 0.1-0.5% Triton X-100 or Tween-20 to reduce hydrophobic interactions

  • Adjust antibody conditions:

    • Reduce primary antibody concentration (try 1:2000 or 1:5000 dilution)

    • Shorten incubation time or switch to 4°C overnight incubation

    • Consider adding competing proteins (1-5% BSA during antibody incubation)

  • Increase stringency of washes:

    • Increase salt concentration in wash buffers (up to 500 mM NaCl)

    • Add detergents to wash buffers (0.1-0.5% SDS or 0.1-1% Triton X-100)

    • Increase number and duration of wash steps

  • Pre-absorb antibody:

    • If available, pre-incubate with immunizing peptide

    • Consider pre-clearing with unrelated yeast lysates

  • Protein extraction modifications:

    • Test different lysis buffers with varying detergent compositions

    • Include additional protease inhibitors to prevent degradation

    • Optimize protein concentration to ensure adequate target representation

How does temperature stress affect YBL065W expression and antibody detection?

Research suggests stress conditions can significantly alter yeast protein expression profiles:

Temperature effects on YBL065W:

  • Heat shock (37-42°C) may induce changes in expression of many dubious ORFs including YBL065W

  • Cold shock (4-15°C) effects are less characterized but may also affect expression

Experimental considerations:

  • When studying YBL065W under temperature stress conditions, collect samples at multiple time points (15 min, 30 min, 1 hr, 2 hr) after temperature shift

  • Compare antibody detection patterns between optimal growth (30°C) and stress temperatures

  • Consider that protein stability and epitope accessibility may change under stress conditions

Correlation with other stress markers:

  • Monitor established stress response proteins (e.g., Hsp70, Hsp90) in parallel

  • Compare YBL065W expression patterns with transcriptomic changes during temperature stress

Methodological adaptations:

  • For heat-shocked samples, include additional protease inhibitors during extraction

  • Consider using phosphatase inhibitors as protein phosphorylation states often change during stress

  • For immunofluorescence applications, optimize fixation conditions as protein localization may change under stress

What is the role of YBL065W in yeast survival during desiccation and rehydration?

YBL065W has been identified among the "High Expressors" in studies examining yeast response to desiccation and rehydration , suggesting a potential role in stress adaptation:

Experimental findings:

  • YBL065W appears in Table S2 listing "High Expressors" in response to desiccation/rehydration stress

  • This suggests upregulation of this dubious ORF under extreme water stress conditions

Research approaches for investigation:

  • Time-course analysis:

    • Monitor YBL065W protein levels at multiple timepoints during desiccation and rehydration

    • Compare with known desiccation response genes

  • Correlation with viability:

    • Assess whether YBL065W expression levels correlate with cell survival rates

    • Determine if heterozygous YBL065W strains show altered desiccation tolerance

  • Localization studies:

    • Use immunofluorescence to track potential changes in subcellular localization during water stress

    • Compare with distribution patterns of other stress-responsive proteins

  • Interaction partners:

    • Perform co-immunoprecipitation under desiccation stress to identify potential stress-specific binding partners

    • Compare interaction networks under normal and stress conditions

How can YBL065W antibodies be utilized in yeast surface display applications?

Yeast surface display (YSD) is a powerful technology for antibody engineering and discovery, and YBL065W antibodies could be employed in this context:

General YSD methodology applicable to YBL065W:

  • YSD allows for the display of proteins on the yeast cell surface through fusion with Aga2p, a cell wall protein

  • The technology enables protein engineering and analyzing protein-protein interactions

Application strategies for YBL065W studies:

  • Surface display of YBL065W for antibody screening:

    • Construct a fusion of YBL065W with Aga2p using Golden Gate Cloning approaches

    • Display the potential protein on yeast surface to confirm antibody specificity

    • Use flow cytometry with fluorescently labeled anti-YBL065W antibodies to quantify binding

  • Antibody engineering applications:

    • Generate and screen anti-YBL065W antibody variants using YSD libraries

    • Optimize antibody affinity and specificity through directed evolution

  • Technical considerations:

    • For optimal display, consider both two-directional (2dir) and bicistronic (bicis) expression systems

    • Ensure proper protein folding by optimizing display conditions (temperature, induction time)

    • Validate surface expression using established detection methods before applying YBL065W antibodies

  • Detection methods:

    • Primary detection: Anti-YBL065W antibody followed by fluorescently-labeled secondary antibody

    • Expression confirmation: Anti-epitope tag antibodies (if tags are incorporated)

    • Apply flow cytometry sorting to isolate high-expressing clones

What is known about the genetic interactions between YBL065W and other essential genes?

Despite being classified as a dubious ORF, YBL065W has been identified as essential in some studies and may have important genetic interactions:

Key findings from genetic screens:

  • YBL065W appears in heterozygous yeast deletion collection screens related to Hsp90 function

  • It is classified as essential, making homozygous deletion strains non-viable

  • Surprisingly, it has no published interactions with any gene/protein according to BioGRID database

Research approaches to explore genetic interactions:

  • Synthetic genetic array (SGA) analysis:

    • Use temperature-sensitive or conditional YBL065W mutants rather than deletions

    • Screen for synthetic lethality or growth defects with other gene mutations

  • Dosage suppression studies:

    • Identify genes that, when overexpressed, can suppress YBL065W mutant phenotypes

    • Test known essential gene pathways for functional relationships

  • Comparative genomics:

    • Analyze conservation patterns across yeast species to identify potential functional relationships

    • Assess co-evolution patterns with other essential genes

  • Protein-protein interaction screening:

    • Use YBL065W antibodies for immunoprecipitation followed by mass spectrometry

    • Employ proximity labeling approaches (BioID, APEX) to identify neighboring proteins

Data interpretation considerations:

  • The dubious annotation and lack of published interactions suggest potential novel biology

  • Consider that essential function might be due to non-coding features overlapping with the YBL065W region

  • Carefully distinguish between direct and indirect genetic interactions

How should I design ChIP experiments using YBL065W antibodies?

Chromatin immunoprecipitation (ChIP) with YBL065W antibodies requires careful experimental design:

Protocol considerations:

  • Crosslinking optimization:

    • Standard: 1% formaldehyde for 10-15 minutes at room temperature

    • For potentially weak interactions: Consider dual crosslinking (1 mM DSG followed by formaldehyde)

  • Chromatin fragmentation:

    • Sonication parameters: Typically 10-15 cycles (30s ON/30s OFF) to achieve 200-500bp fragments

    • Enzymatic digestion alternative: MNase treatment for more precise fragmentation

  • Immunoprecipitation conditions:

    • Antibody amount: Begin with 2-5μg per sample, optimize if necessary

    • Incubation: Overnight at 4°C with rotation

    • Beads: Protein A/G or magnetic beads pre-blocked with BSA and sperm DNA

  • Controls required:

    • Input chromatin (pre-IP sample)

    • Non-specific IgG antibody control

    • No-antibody control

    • Positive control region: Use primer sets for well-established binding sites of other proteins

  • Analysis methods:

    • qPCR for candidate regions

    • ChIP-seq for genome-wide binding profile

Data interpretation for dubious ORFs:

  • Compare binding profiles with known transcription factors and chromatin modifiers

  • Correlate binding sites with transcriptomic data to assess functional relevance

  • Consider that binding might indicate non-coding regulatory functions rather than protein activity

Based on available protocols from similar yeast ChIP experiments , special attention should be given to optimizing antibody concentration and washing stringency due to the questionable nature of the target.

What approaches should be used for measuring YBL065W expression changes during cell cycle progression?

To effectively monitor YBL065W expression throughout the cell cycle:

Synchronization methods suitable for YBL065W studies:

  • α-factor arrest/release (for MATa cells):

    • Treat with α-factor (1-5 μg/mL) for 2-3 hours until >90% cells show shmoo morphology

    • Release by washing and resuspending in fresh media

    • Collect samples every 15-20 minutes for 2-3 cell cycles

  • Nocodazole block/release:

    • Treat with 15 μg/mL nocodazole for 3 hours

    • Release by washing and resuspending in fresh media

    • Collect samples every 15 minutes

  • Centrifugal elutriation:

    • Isolate G1 cells based on size

    • Allow synchronized growth and collect samples at defined intervals

Analysis methods:

  • Western blotting with YBL065W antibodies:

    • Include cyclins (Cln2, Clb5) as cell cycle phase markers

    • Normalize to loading controls (e.g., actin)

  • Immunofluorescence microscopy:

    • Co-stain with DNA (DAPI) and bud morphology markers

    • Quantify signal intensity relative to cell cycle stage

  • Flow cytometry:

    • Combine DNA content staining (propidium iodide) with antibody staining

    • Use fluorescently-labeled YBL065W antibodies for protein detection

Data integration:

  • Plot YBL065W protein levels against established cell cycle markers

  • Compare with transcriptomic data on YBL065W mRNA expression during cell cycle

  • Assess correlation with related essential genes to identify potential functional clusters

This approach will help determine whether YBL065W, despite its dubious annotation, shows cell cycle-regulated expression suggestive of a functional role.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.